IPD 0.00% 5.8¢ impedimed limited

Ann: FDA Grants Breakthrough Device Designation for Renal Failure, page-4

  1. 1,040 Posts.
    lightbulb Created with Sketch. 358
    Pretty significant news, all of a sudden there are potential multiple revenue streams from lymphedema, heart and renal. Could be a cash cow in 2022.... current MC pretty cheap given the potential, I just hope we don't get taken over beforehand because the hawks must be circling.
 
watchlist Created with Sketch. Add IPD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.